Home > Journals > Minerva Biotecnologica > Past Issues > Minerva Biotecnologica 2004 June;16(2) > Minerva Biotecnologica 2004 June;16(2):135-43

CURRENT ISSUEMINERVA BIOTECNOLOGICA

A Journal on Biotechnology and Molecular Biology


Indexed/Abstracted in: EMBASE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,246


eTOC

 

ORIGINAL ARTICLES  CELLULAR AND MOLECULAR ADVANCES IN THE STUDY OF INFLAMMATION


Minerva Biotecnologica 2004 June;16(2):135-43

language: English

Induction of apoptosis of human osteoclasts by the transcription factor decoy approach: relevance for the treatment of rheumatoid arthritis

Piva R. 1, Gambari R. 1, 2

1 Department of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy;
2 Interdisciplinary Center for Studies on Inflammation, University of Ferrara, Ferrara, Italy


FULL TEXT  REPRINTS


Rheumatoid arthritis (RA) is characterised by the presence of an inflammatory synovitis accompanied by destruction of joint cartilage and bone. Several evidences, both in vitro and in animal models, indicate that osteoclasts (OCs) are key mediators of all forms of bone erosions and loss in RA. Interestingly, transcription factor decoy (TFD) oligonucleotides targeting nuclear factor κB (NF-kB) are able to induce apoptosis of human primary OCs. This effect is associated with an increase of caspase-3 and a decrease of interleukin-6 production. Therefore, the effects of NF-kB decoys on OCs may be relevant for the development of treatments of RA. Accordingly, several evidences suggest apoptosis as a target for therapy of this inflammatory disease.

top of page